Industry News
Annual AusBiotech-GSK Student Excellence Awards open now
The annual AusBiotech-GSK Student Excellence Awards aim to recognise and encourage promising research students and to raise awareness of research translation and applications. [ + ]
GSK Research Excellent Award nominations closing soon
Nominations for the $80,000 GlaxoSmithKline Australia Award for Research Excellence are closing at the end of April. [ + ]
Academy of Science awards Australia’s top scientists
The Australian Academy of Science will present its highest awards to eminent scientists on Thursday 3 May 2012 for contributions to their fields of research. [ + ]
Australian and Israeli researchers team up against obesity
Scientists from Israel’s Weizmann Institute of Science will be visiting Australia in May to foster and invest in new collaborations with Australian researchers to tackle obesity. [ + ]
CPI figures show PBS safety net is working: Medicines Australia
A 14.1% spike in the pharmaceutical component of the CPI is not down to a price hike, but instead shows that the PBS safety net is fulfilling its purpose, Medicines Australia's CEO says. [ + ]
Mao’s Last Dancer to speak at AusMedtech
The 2012 AusMedtech national conference to be held in less than three weeks will feature inspirational speaker Li Cunxin, well known to many as Mao’s Last Dancer, amidst the program of over 40 speakers and panel sessions. [ + ]
Three Australian Academy of Science Fellows elected to Royal Society
Three Fellows of the Australian Academy of Science have been elected to the Royal Society of London, the oldest scientific academy in continuous existence. Professor Brian Schmidt, Professor Hugh O’Neill and Dr Trevor McDougall are among 44 scientists elected to the Royal Society in 2012. [ + ]
New ultra-small laser opens up a world of possibilities
Computing and medicine are among the many fields which could be revolutionised by a new form of ultra-small laser. [ + ]
Biota merger to open US markets and investment
A merger between Biota and US-based Nabi Pharmaceuticals will see Biota delist from the ASX and list on the Nasdaq with the aim of improving investment and commercialisation opportunities. [ + ]
Bullish biotech industry set to increase staffing
Fifty Australian biotechnology companies plan to spend at least $610 million on research and development in 2012 and 82% expect their business to grow this year according to AusBioTech’s annual Biotechnology Industry Position Survey. [ + ]
White Rabbit project to develop an advanced communications technology with ns accuracy
University of Granada researchers, in collaboration with the European Organization for Nuclear Research (CERN), are working on the development of an extremely precise communications and synchronisation system that has an accuracy of one nanosecond. Researchers plan to integrate this system into CERN's accelerators; more specifically, into the Large Hadron Collider (LHC), the world's largest and highest-energy particle accelerator. [ + ]
Pharmaxis gets marketing nod for Bronchitol in EU
Pharmaxis (ASX:PXS) has secured marketing approval from the EU for its flagship cystic fibrosis drug, Bronchitol. [ + ]
Massive upgrades to research and education data connectivity between Australia and the world
AARNet and Southern Cross Cable Networks (SCCN) have announced the extension of their SXTransPORT partnership to provide huge upgrades to research and education data connectivity between Australia and the rest of the world. The partnership will see SCCN deliver dual 40 Gbps circuits in 2012 and upgrades to dual 100 Gbps by 2016. [ + ]
Inaugural AusBiotech AEI & AusFoodtech networking event hits the mark
The inaugural AusBiotech AEI (Agricultural Environment and Industrial biotechnology) & AusFoodtech event attracted 70 attendees from around Australia, representing the food, agricultural, industrial and environmental sectors of biotechnology. [ + ]
Coridon gears up for herpes vaccine trial
Prospects for a herpes cure are closer with Coridon signing a deal covering technology used in its experimental herpes vaccine, which is set to enter human trials this year. [ + ]